Impact Of Neratinib On Outcomes In Her2-Positive Metastatic Breast Cancer Patients With Central Nervous System Disease At Baseline: Findings From The Phase 3 Nala Trial

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY(2021)

引用 4|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要